Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Half-effective Dose of Remimazolam Tosilate with Alfentanil for Painless Gastroscopy in Elderly Patients
ChiCTR2200057653Phase 4Not yet recruiting
- Sponsor
- Jiaxing Second Hospital
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam in procedural pain (3 arms), sponsored by Jiaxing Second Hospital. Primary endpoint: Placement reaction. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
procedural pain
Beyond the preview
Go deeper on ChiCTR2200057653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057653.